1. Improvement of bone mineral density after enzyme replacement therapy in Chinese late-onset Pompe disease patients.
- Author
-
Bun Sheng, Yim Pui Chu, Wa Tai Wong, Eric Kin Cheong Yau, Pak Lam Chen, Sammy, and Wing Hang Luk
- Subjects
BONE density ,THERAPEUTIC use of enzymes ,GLYCOGEN storage disease type II ,CHINESE people ,GLUCOSIDASES ,SEVERITY of illness index ,PATIENTS ,DISEASES - Abstract
Objective: Late-onset Pompe disease (LOPD) is a lysosomal storage disease resulted from deficiency of the enzyme acid α-glucosidase. Patients usually develop a limb-girdle pattern of myopathy and respiratory impairment, and enzyme replacement therapy (ERT) is the only specific treatment available. Recently, LOPD has been associated with low bone mineral density (BMD), but the effect of ERT on BMD is inconclusive. In this report we described our early observations on the change of BMD after ERT in Chinese LOPD patients. Results: We studied four Chinese LOPD patients with different severities of myopathy. All were underweight, and three had osteoporosis at baseline. We found significant weight gain in three patients after ERT and all four patients showed improvement in BMD. The biggest improvement, 84.4% increase in BMD, was seen in a lady with the most prominent weight recovery. Our results suggest that ERT improves BMD in Chinese LOPD and weight gain could be a major contributor to this effect. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF